Treatment of patients suffering from psoriasis in cases of resistance to Infliximab
Author(s) -
M M Butareva,
L. F. Znamenskaya,
A A Martynov
Publication year - 2011
Publication title -
vestnik dermatologii i venerologii
Language(s) - English
Resource type - Journals
eISSN - 2313-6294
pISSN - 0042-4609
DOI - 10.25208/vdv1092
Subject(s) - infliximab , psoriasis , medicine , dermatology , drug , tumor necrosis factor alpha , pharmacology
The authors describe cases from the clinical practice of efficient use of preformed physical factors, general PUVAbaths, in treatment of psoriasis patients who have previously received treatment with Infliximab, an anti-cytokine drug(Remicade).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom